In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
October 9th, 2004 | 18 | Yes |
Popular Name: Loxoprofen Sodium Loxoprofen Sodium
Find On: PubMed — Wikipedia — Google
CAS Numbers: 68767-14-6 , 80382-23-6 , [68767-14-6] , [80382-23-6]
(+-)-((2-oxocyclopentyl)methyl)hydratropic acid
2-(4-((2-Oxocyclopentyl)methyl)phenyl)propanoic acid
2-[4-(2-Oxo-cyclopentylmethyl)-phen; yl]-propionic acid
2-[4-(2-Oxo-cyclopentylmethyl)-phenyl]-propionic acid
2-{4-[(2-oxocyclopentyl)methyl]phenyl}propanoate
68767-14-6; D08149; Loxoprofen (INN)
80382-23-6; D01709; Lorfenamin (TN); Loxonin (TN); Loxoprofen sodium hydrate (JP16)
alpha-Methyl-4-[(2-oxocyclopentyl)methyl]benzeneacetic acid
CPD000469165; LOXOPROFEN SODIUM
CPD000469165; LOXOPROFEN SODIUM; SAM001246594
CPD000469165; SAM001246594; sodium loxoprofen
Loxoprofen (high-melting polymorph)
loxoprofen; loxoprofene; loxoprofeno; loxoprofenum
Sodium 2-{4-[(2-oxocyclopentyl)methyl]phenyl}propanoate
Sodium; (R)-2-[4-((S)-2-oxo-cyclopentylmethyl)-phenyl]-propionate
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 2.79 | 9.48 | -51.05 | 0 | 3 | -1 | 57 | 245.298 | 4 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
mechanism | . | ZereneX Building Blocks |
Purity | 95% | Fluorochem |
biological_use | Analgesic | IBScreen Bioactives |
Indications | analgesic, NSAID | KeyOrganics Bioactives |
biological_use | Analgesic | IBScreen Bioactives |
PUBCHEM_SUBSTANCE_COMMENT | NCC_SAMPLE_SUPPLIER : Sequoia Research Products Ltd.; NCC_SUPPLIER_STRUCTURE_ID : SRP01595l; 1 Sodium | NIH Clinical Collection via PubChem |
mechanism | Non-selective cyclooxygenase inhibitor | IBScreen Bioactives IBScreen Bioactives |
biological_use | Non-steroidal antiinflammatory agent | IBScreen Bioactives |
PUBCHEM_SUBSTANCE_COMMENT | SAMPLE_SUPPLIER: Sequoia Research Products Ltd.; SUPPLIER_STRUCTURE_ID: SRP01595l; SALT: 1 Sodium | NIH Clinical Collection via PubChem |
mechanism | Works by reducing the synthesis of prostaglandins from arachidonic acid | IBScreen Bioactives |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
PGH1-2-E | Cyclooxygenase-1 (cluster #2 Of 6), Eukaryotic | Eukaryotes | 6500 | 0.40 | Binding ≤ 10μM |
PGH2-6-E | Cyclooxygenase-2 (cluster #6 Of 8), Eukaryotic | Eukaryotes | 10000 | 0.39 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
PGH1_HUMAN | P23219 | Cyclooxygenase-1, Human | 6500 | 0.40 | Binding ≤ 10μM |
PGH2_HUMAN | P35354 | Cyclooxygenase-2, Human | 10000 | 0.39 | Binding ≤ 10μM |
Description | Species |
---|---|
COX reactions | |
Nicotinamide salvaging | |
Synthesis of 15-eicosatetraenoic acid derivatives | |
Synthesis of Prostaglandins (PG) and Thromboxanes (TX) |